Credo (CRDO) Form 4: James Laufman sells 10,000 shares near $140
Rhea-AI Filing Summary
James Laufman, the Chief Legal Officer and Secretary of Credo Technology Group Holding Ltd (CRDO), reported the sale of 10,000 ordinary shares on 09/05/2025. The sale was executed in multiple trades at prices ranging from $140.00 to $140.02, with the form reporting a weighted average sale price of $140.0019. After the reported transaction, Laufman beneficially owned 232,284 ordinary shares. The Form 4 discloses the transaction code as an ordinary sale and affirms the reporter's willingness to provide detailed trade information on request.
Positive
- Timely, specific disclosure of trade details including weighted average price and willingness to provide per-trade information
- Reporting person identified with role (Chief Legal Officer, Secretary) and post-transaction beneficial ownership of 232,284 shares
Negative
- Insider sale of 10,000 shares without disclosure of a 10b5-1 trading plan or stated rationale
- Sale size represents a modest reduction in holdings (approximately 4% of prior reported position) which some investors may interpret as a negative signal
Insights
TL;DR: Insider sale of 10,000 shares at roughly $140 each, leaving 232,284 shares outstanding for the reporting person.
The transaction is a routine insider sale rather than an option exercise or derivative transaction. The sale size (10,000 shares) represents a modest portion of the reporting person’s post-transaction holdings, decreasing reported beneficial ownership from roughly 242,284 shares to 232,284 shares. The reported weighted average price of $140.0019 provides precise execution detail and the filer offers to supply per-trade data on request, which supports transparency. There is no additional context about purpose of the sale or any related trading plan disclosed on the form.
TL;DR: Disclosure is compliant and detailed; sale appears administrative but lacks stated rationale or 10b5-1 plan reference.
The Form 4 shows clear identification of the reporting person’s role and the specific sale details, meeting Section 16 reporting requirements. The form does not check the box indicating the transaction was made pursuant to a Rule 10b5-1 trading plan, and no explanatory rationale is provided. From a governance perspective, timely and specific disclosure is positive, but absence of a trading-plan indicator means observers cannot confirm whether the sale was pre-planned or discretionary.